Safety & Efficacy of ALT-711 (Alagebrium) in Chronic Heart Failure

Clinical trial NCT00739687 · TERMINATED

Trial details

NCT number: NCT00739687
Sponsor: Synvista Therapeutics, Inc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Heart Failure

Start date: 2008-08-01
Primary completion: 2009-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.